We believe Dish Network Corp.�� (DISH) decision to stop pursuing Sprint was a boon in disguise for the latter as it allowed SoftBank to modify its offer. In June, SoftBank raised its bid offer to $21.6 billion from its initial $20.1 billion offer in exchange of a 78% stake in Sprint, up from the initial proposal of 70% holding. The revised offer represented an increase of 35 cents per share in the purchase price to $7.65 from $7.30.
Top 10 Defensive Companies To Buy For 2015: Thermo Fisher Scientific Inc(TMO)
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacture, analysis, discovery, and diagnostics. Its Analytical Technologies segment offers analytical instruments to analyze prepared samples, software interpretation tools, laboratory information management systems, and laboratory automation systems; environmental instruments and integrated systems for environmental monitoring, safety, and security applications; and process instruments, integrated systems, and measurement solutions. It also provides diagnostics products used in healthcare laboratories to prepare and analyze patient samples; and biosciences products comprising reagents and consumables used in life science research, drug discovery, and biopharmaceutical production. The company?s Laboratory Products and Services segment offers laboratory equipment, including sample preparation, environment storage and handling equipment, and laboratory workstations; laboratory consumables; research market solutions consisting of chemicals, instruments and apparatus, liquid handling pumps and devices, and capital equipment and consumables; and healthcare market products comprising analytical equipment, diagnostic tools, and reagents and consumables. It also provides workplace and first responder equipment, protective gear, and apparel; and packaging, warehousing, distribution, labeling, pharmaceutical and biospecimen storage, and analytical laboratory services in the area of drug discovery and pharmaceutical clinical trials. The company serves pharmaceutical and biotechnology companies, hospitals and clinical diagnostic labs, universities, research institutions, government agencies, and environmental and industrial process control settings primarily in the United States, Germany, and the United Kingdom. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Advisors' Opinion:- [By Tess Stynes]
General Electric Co.'s(GE) healthcare unit agreed to acquire several of Thermo Fisher Scientific Inc.'s(TMO) life-sciences businesses for roughly $1.06 billion.
- [By Monica Gerson]
Breaking news
Shares of PepsiCo (NYSE: PEP) gained more than 2% in pre-market trading after the company reported better-than-expected second-quarter results and raised its full-year earnings outlook. To read the full news, click here. Eagle Pharmaceuticals (NASDAQ: EGRX) today announced that the U. S. Food and Drug Administration (FDA) has approved Ryanodex庐 (dantrolene sodium) for injectable suspension indicated for the treatment of malignant hyperthermia (MH), along with the appropriate supportive measures. To read the full news, click here. Shares of Whirlpool (NYSE: WHR) tumbled more than 5% in pre-market trading after the company reported weaker-than-expected second-quarter profit. To read the full news, click here. Thermo Fisher Scientific (NYSE: TMO) reported upbeat second-quarter results. To read the full news, click here.Posted-In: Baird US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets
Top 5 Japanese Stocks To Buy For 2014: Spectrum Pharmaceuticals Inc.(SPPI)
Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company, primarily focuses on oncology and hematology. The company engages in acquiring, developing, and commercializing a broad and diverse pipeline of late-stage clinical and commercial products. It markets Zevalin, a prescribed form of cancer therapy, radioimmunotherapy; and Fusilev, a novel folate analog formulation and the pharmacologically active isomer of the racemic compound, calcium leucovorin. The company?s drugs in late stage development include Apaziquone, an anti-cancer agent; and Belinostat, a histone deacytelase inhibitor. Its drugs in development also include Ozarelix a luteinizing hormone releasing hormone antagonist, which is in Phase II clinical stage; SPI-1620, a peptide agonist of endothelin B receptors, which is in Phase I clinical stage; and RenaZorb, a lanthanum-based nanoparticle phosphate binding agent, which is in preclinical stage. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was founded in 1987 and is based in Henderson, Nevada.
Advisors' Opinion:- [By Jake L'Ecuyer]
Spectrum Pharmaceuticals (NASDAQ: SPPI) shares tumbled 9.77 percent to $8.18 after the company announced an offering of $100 million of convertible notes.
- [By Ben Levisohn]
Spectrum Pharmaceuticals (SPPI) has risen 4.7% to $9.30 after being granted accelerated approval for its lymphoma drug.
SeaWorld Entertainment (SEAS) has jumped 1.7% to $29.59 after the theme-park operator was upgraded to Buy from Neutral at Longbow.
Top 5 Japanese Stocks To Buy For 2014: Global Links Corp (GLCO)
Global Links Corp. (Global Links) is engaged in real estate acquisitions and development, real estate information services and international housing projects. The Company owns approximately 996 undeveloped residential lots in the Valle Vista Subdivision. This land consists of residential lots that have not yet been developed. The Company's office building comprises 9,300 square feet, which is acquired as an empty shell, in June 2004, and completed tenant improvements in October 2004. As at December 31, 2005, the Sunset Office Building is wholly occupied. The Company occupies 15% of the building; the remaining 85% is occupied by Southwest Title Company. In August 2013, Global Links Corp. announced that the formation of a wholly owned subsidiary named Domain Micro Homes.
During the year ended December 31, 2002, the Company decided to pursue the business of marketing electronic transactions by offering a suite of electronic products and proceeded to establish relationships with various companies that provide such products and others that specialize in the marketing of these products. During the year ended December 31, 2003, Global Links transferred all of the assets and liabilities relating to the business of marketing electronic transactions to its wholly owned subsidiary, Global Links Card Services, Inc. (GLCS). In December 2004, the Company sold all of its interests in GLCS to an unrelated corporation. Also during the year ended December 31, 2003, the Company merged with Capitol Group Holding Corporation and in addition to the marketing of electronic transactions products, the Company entered the business of real estate acquisitions and development, real estate information services and international housing projects.
Advisors' Opinion:- [By Peter Graham]
Small cap stocks Green Endeavors Inc (OTCMKTS: GRNE), Global Links Corporation (OTCMKTS: GLCO) and Vitamin Blue Inc (OTCBB: VTMB) were all making noticeable moves at the end of last week. On Friday, Green Endeavors Inc rose 8.11% and Global Links Corporation rose 13.96% while Vitamin Blue Inc fell 10%. Of course, small cap OTC stocks making large single digit or double digit moves in either direction aren�� all that unusual. Moreover, all of these small caps have been the subject of paid promotions. With that in mind, here is a closer look at all three to help you decide on an investing or trading strategy:
Top 5 Japanese Stocks To Buy For 2014: Humboldt Capital Corp (HMB)
Humboldt Capital Corporation (Humboldt) is an investment company with its holdings concentrated in the resource sector. The Company�� principal business is to purchase securities for investment income and capital appreciation over the long term. The Company provides early-stage risk capital, business experience and guidance to junior oil and gas enterprises. Humboldt is engaged in making investments in a range of very small to large companies, which are in turn engaged in the exploration, development, production and acquisition of crude oil and natural gas or minerals, or companies, which provides services to such companies. Humboldt also makes investments in other businesses that have potential for growth. Humboldt has investments in western Canadian energy companies, international oil and gas companies and in the mining sector, with particular emphasis on companies exploring or producing commodities. Advisors' Opinion:- [By Inyoung Hwang]
EasyJet Plc and International Consolidated Airlines Group SA climbed as oil prices fell after the U.S. and Russia agreed on a plan to destroy Syrian chemical weapons. Hennes & Mauritz AB (HMB) advanced to a three-year high after sales topped estimates. Remy Cointreau SA (RCO) soared the most in almost four years as Chinese cognac shipments increased.
No comments:
Post a Comment